[Antimicrobial therapy in neutropenia].
Maschmeyer
G
G
Abteilung für Hämatologie, Onkologie und Tumorimmunologie, Robert-Rössle-Klinik am Max-Delbrück-Centrum für Molekulare Medizin, Medizinische Fakultät, Humboldt-Universität zu Berlin. maschmeyer@rrk-berlin.de
Vogt
K
K
Hahn
H
H
Dörken
B
B
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D005335:Fever of Unknown Origin / Q000188:drug therapy / Q000209:etiology; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors